Marco Anelli is R&D Director at Keypharma, an Italy-based ProductLife Group company, and is responsible for the coordination of all clinical and preclinical aspects of projects run internally and on behalf of clients. Drawing on a career in the pharmaceutical industry that spans 25 years, Marco provides expert oversight on a wide range of R&D activities. Marco has participated in and coordinated all stages of drug development — from formulation to Phase I-IV and pharmacovigilance. In addition, Marco is a qualified QPPV and has prepared and overseen more than 200 non-clinical and clinical overviews and summaries. Before joining Keypharma, Marco was Medical Affairs Director at Eurand. In recent years, has worked extensively in the fields of pharmacoeconomics and health technology assessment. He has a medical degree from Milan University and an international master’s degree in health economics and pharmacoeconomics from Pompeu Fabra University in Barcelona.